December 14, 2015

Complix Advances Novel Biospecific ImmunotherapeuticCMX-02 – Enters Agreement with Selexis to Access SUREtechnology Platform

Read More
November 05, 2015

Agenus to Acquire Antibody Manufacturing Capability, Expands Antibody Discovery and adds Cell Line Development Capabilities with Three Separate Transactions

Read More
November 03, 2015

Faron Enters Agreement with Selexis SA to Progress Development of Novel Cancer Immunotherapy Clevegen

Read More
September 22, 2015

Selexis SA Announces Service Agreement with Swedish Orphan Biovitrum AB (Sobi)

Read More
May 20, 2015

Merus and Selexis Receive a €2.1 Million Grant for Single-Cell-Line Manufacturing of a Bispecific Antibody Combination to Treat Colorectal Cancer

Read More
January 22, 2015

Selexis-Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing

Read More
January 08, 2015

First Selexis SUREtechnology-Generated Therapeutic Monoclonal Antibody Approved for Market

Read More